title: Neuro-Behçet: acute and sequential aspects by MRI and MRS.
abstract: Three patients with neuro-Behçet underwent MRI and MRS during acute illness. After therapy, MRI and MRS were performed in 3 and 1 patients, respectively. MRI revealed a marked improvement of the initial lesion in 2, a complete remission in 1 patient. MRS showed a reduction of the N-acetyl-aspartate (NAA)/phosphocreatine (CR) ratio within the acute lesion in all patients and a normalization in the follow-up spectrum of the examined patient.
authors.affiliation: MR-Center, Inselspital, Bern, Switzerland.
authors.forename: F
authors.initials: F
authors.lastname: Nüssel
authors.forename: H
authors.initials: H
authors.lastname: Wegmüller
authors.forename: F
authors.initials: F
authors.lastname: Laseyras
authors.forename: S
authors.initials: S
authors.lastname: Posse
authors.forename: N
authors.initials: N
authors.lastname: Herschkowitz
authors.forename: P
authors.initials: P
authors.lastname: Huber
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000032:analysis; D001528:Behcet Syndrome / Q000175:diagnosis* / Q000188:drug therapy; D001921:Brain / Q000473:pathology; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D008582:Meningitis, Aseptic / Q000175:diagnosis* / Q000188:drug therapy; D010725:Phosphocreatine / Q000032:analysis*
chemical_list: D000305:Adrenal Cortex Hormones; D010725:Phosphocreatine; D002699:Chlorambucil; D001224:Aspartic Acid; D003520:Cyclophosphamide; C000179:N-acetylaspartate